Skip to main content
Erschienen in:

18.03.2021 | Original Paper

A Proactive Policy to Eliminate Viral Hepatitis Infection: Five-Year Results for the Subdistrict Model in Thailand

verfasst von: Vallop Thaineua, Opart Karnkavinpong, Patrinee Traisathit, Somkid Lertkietidamrong, Swong Maiton, Pimwarat Nanthaprut, Taned Chitapanarux

Erschienen in: Journal of Community Health | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to ascertain hepatitis B (HBV) and hepatitis C (HCV) infection rates in individuals toward the early initiation of treatment and prevention of developing hepatocellular carcinoma (HCC). This cross-sectional study was performed on 2084 participants from two subdistricts in Chiang Mai and Lampang provinces, northern Thailand. Screening for viral hepatitis in the general population was conducted at subdistrict health-promoting hospitals in Nong Pa Krang, in the suburb of Chiang Mai city, and Thoenburi, a subdistrict in the rural area of Lampang province, northern Thailand. Ninety-one (4.4%) participants tested positive for either HBV or HCV, with 3.3% of all participants infected with HBV and 1.1% infected with HCV. Treatment follow-up was 29.0% of HBV and 54.5% of HCV. A proactive approach to eliminate viral hepatitis can be carried out at the subdistrict level in Thailand. Success could increase participation in other subdistricts in a cascade-like manner by 2030. The identified factors of success are leadership by the local government supported by the Local Health Fund and Village Health Volunteers.
Literatur
1.
Zurück zum Zitat Dasgupta, P., Henshaw, C., Youlden, D. R., Clark, P. J., Aitken, J. F., & Baade, P. D. (2020). Global trends in incidence rates of primary adult liver cancers: A systematic review and meta-analysis. Frontiers in Oncology, 10, 171.CrossRef Dasgupta, P., Henshaw, C., Youlden, D. R., Clark, P. J., Aitken, J. F., & Baade, P. D. (2020). Global trends in incidence rates of primary adult liver cancers: A systematic review and meta-analysis. Frontiers in Oncology, 10, 171.CrossRef
3.
Zurück zum Zitat Mohammadian, M., Mahdavifar, N., Hafshejani, A. M., & Salehiniya, H. (2018). Liver cancer in the world: Epidemiology, incidence, mortality and risk factors. World Cancer Research Journal, 5(2), e1082. Mohammadian, M., Mahdavifar, N., Hafshejani, A. M., & Salehiniya, H. (2018). Liver cancer in the world: Epidemiology, incidence, mortality and risk factors. World Cancer Research Journal, 5(2), e1082.
4.
Zurück zum Zitat Virani, S., Bilheem, S., Chansaard, W., Chitapanarux, I., Daoprasert, K., Khuanchana, S., et al. (2017). National and subnational population-based incidence of cancer in Thailand: Assessing cancers with the highest burdens. Cancers, 9(8), 108.CrossRef Virani, S., Bilheem, S., Chansaard, W., Chitapanarux, I., Daoprasert, K., Khuanchana, S., et al. (2017). National and subnational population-based incidence of cancer in Thailand: Assessing cancers with the highest burdens. Cancers, 9(8), 108.CrossRef
5.
Zurück zum Zitat Mason, L., Veldhuijzen, I. K., Duffell, E., vanAhee, A., Bunge, E. M., Amato‐Gauci, A. J., et al. (2019). Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review. Journal of Viral Hepatitis, 26(12), 1431–1453.CrossRef Mason, L., Veldhuijzen, I. K., Duffell, E., vanAhee, A., Bunge, E. M., Amato‐Gauci, A. J., et al. (2019). Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review. Journal of Viral Hepatitis, 26(12), 1431–1453.CrossRef
6.
Zurück zum Zitat Tao, J., Zhang, W., Yue, H., Zhu, G., Wu, W., Gong, W., et al. (2019). Prevalence of hepatitis B virus infection in Shenzhen, China, 2015–2018. Scientific Reports, 9, 13948.CrossRef Tao, J., Zhang, W., Yue, H., Zhu, G., Wu, W., Gong, W., et al. (2019). Prevalence of hepatitis B virus infection in Shenzhen, China, 2015–2018. Scientific Reports, 9, 13948.CrossRef
7.
Zurück zum Zitat Wright, C. M., Boudarène, L., Ha, N. T., Wu, O., & Hawkins, N. (2018). A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries. BMC Public Health, 18(1), 373.CrossRef Wright, C. M., Boudarène, L., Ha, N. T., Wu, O., & Hawkins, N. (2018). A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries. BMC Public Health, 18(1), 373.CrossRef
8.
Zurück zum Zitat Department of Disease Control of Thailand. (2020). Thailand practice guideline for eliminate hepatitis C [in Thai]. Bangkok, Thailand. Department of Disease Control of Thailand. (2020). Thailand practice guideline for eliminate hepatitis C [in Thai]. Bangkok, Thailand.
9.
Zurück zum Zitat Thai Association for the Study of the Liver. (2015). Thailand practice guideline for management of chronic [in Thai]. Bangkok, Thailand. Thai Association for the Study of the Liver. (2015). Thailand practice guideline for management of chronic [in Thai]. Bangkok, Thailand.
Metadaten
Titel
A Proactive Policy to Eliminate Viral Hepatitis Infection: Five-Year Results for the Subdistrict Model in Thailand
verfasst von
Vallop Thaineua
Opart Karnkavinpong
Patrinee Traisathit
Somkid Lertkietidamrong
Swong Maiton
Pimwarat Nanthaprut
Taned Chitapanarux
Publikationsdatum
18.03.2021
Verlag
Springer US
Erschienen in
Journal of Community Health / Ausgabe 5/2021
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-021-00977-2